Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits

Biol Pharm Bull. 2018;41(5):828-832. doi: 10.1248/bpb.b18-00046.

Abstract

Selenoprotein P (SeP) is a selenium (Se)-rich extracellular protein. SeP is identified as a hepatokine, causing insulin resistance in type 2 diabetes. Thus, the measurement of SeP in serum has received much attention, and several enzyme-linked immunosorbent assay (ELISA) kits for SeP determination are now commercially available. In the present study, we determined the serum SeP levels by our original ELISA and sol particle homogeneous immunoassay (SPIA) methods and also by commercially available kits, and these determinants were compared. We found a kit-dependent correlation of the determinants with our methods. These results suggest that the selection of kit is critical for comparison with our previous reports and for discussing the relationship between the serum SeP levels and disease condition.

Keywords: commercially available kit; enzyme-linked immunosorbent assay (ELISA); monoclonal antibody; selenoprotein P; sol particle homogeneous immunoassay (SPIA).

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Female
  • Humans
  • Immunoassay / methods*
  • Male
  • Middle Aged
  • Reproducibility of Results
  • Selenoprotein P / blood*

Substances

  • Selenoprotein P